MANOCEPT Trademark

Trademark Overview

On Tuesday, July 17, 2018, a trademark application was filed for MANOCEPT with the United States Patent and Trademark Office. The USPTO has given the MANOCEPT trademark a serial number of 88041351. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 21, 2020. This trademark is owned by Navidea Biopharmaceuticals, Inc.. The MANOCEPT trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE DIAGNOSIS AND TREATMENT OF MACROPHAGE-MEDIATED DISORDERS
manocept

General Information

Serial Number88041351
Word MarkMANOCEPT
Filing DateTuesday, July 17, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, September 21, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 18, 2018

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR THE DIAGNOSIS AND TREATMENT OF MACROPHAGE-MEDIATED DISORDERS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 20, 2018
Primary Code005
First Use Anywhere DateSaturday, June 7, 2014
First Use In Commerce DateSaturday, June 7, 2014

Trademark Owner History

Party NameNavidea Biopharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDublin, OH 43017
Party NameNavidea Biopharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDublin, OH 43017

Trademark Events

Event DateEvent Description
Monday, September 21, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, September 21, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, March 10, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, March 10, 2020FINAL REFUSAL E-MAILED
Tuesday, March 10, 2020SU - FINAL REFUSAL - WRITTEN
Tuesday, March 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 2, 2020ASSIGNED TO LIE
Thursday, February 27, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 4, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 4, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 30, 2019ASSIGNED TO EXAMINER
Tuesday, August 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 27, 2019NON-FINAL ACTION E-MAILED
Tuesday, August 27, 2019SU - NON-FINAL ACTION - WRITTEN
Friday, August 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 15, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, August 12, 2019USE AMENDMENT FILED
Thursday, August 15, 2019EXTENSION 1 GRANTED
Monday, August 12, 2019EXTENSION 1 FILED
Thursday, August 15, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 12, 2019TEAS EXTENSION RECEIVED
Monday, August 12, 2019TEAS STATEMENT OF USE RECEIVED
Monday, August 12, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 12, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 12, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 18, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 18, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 5, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, November 4, 2018ASSIGNED TO EXAMINER
Friday, July 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 20, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

manocept mediated disorders macrophage treatment preparations diagnosis pharmaceutical